[Norfloxacin: a new oral chemotherapeutic agent effective against multi-drug-resistant Gram-negative bacteria and cocci. Rational directions for treatment].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D002056:Burns / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009643:Norfloxacin; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014946:Wound Infection / Q000517:prevention & control*
D009268:Nalidixic Acid; D009643:Norfloxacin
La norfloxacina: un nuovo chemioterapico orale attivo su cocchi e gram-negativi pluriresistenti. Indirizzi razionali di terapia.